Cargando…
Targeting FMN, TPP, SAM-I, and glmS Riboswitches with Chimeric Antisense Oligonucleotides for Completely Rational Antibacterial Drug Development
Antimicrobial drug resistance has emerged as a significant challenge in contemporary medicine due to the proliferation of numerous bacterial strains resistant to all existing antibiotics. Meanwhile, riboswitches have emerged as promising targets for discovering antibacterial drugs. Riboswitches are...
Autores principales: | Pavlova, Nikolet, Traykovska, Martina, Penchovsky, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668854/ https://www.ncbi.nlm.nih.gov/pubmed/37998809 http://dx.doi.org/10.3390/antibiotics12111607 |
Ejemplares similares
-
Targeting SAM-I Riboswitch Using Antisense Oligonucleotide Technology for Inhibiting the Growth of Staphylococcus aureus and Listeria monocytogenes
por: Traykovska, Martina, et al.
Publicado: (2022) -
Bioinformatics and Genomic Analyses of the Suitability of Eight Riboswitches for Antibacterial Drug Targets
por: Pavlova, Nikolet, et al.
Publicado: (2022) -
The glmS Riboswitch Integrates Signals from Activating and Inhibitory Metabolites In Vivo
por: Watson, Peter Y., et al.
Publicado: (2011) -
Phosphatase-Inert Glucosamine 6-Phosphate Mimics
Serve as Actuators of the glmS Riboswitch
por: Fei, Xiang, et al.
Publicado: (2014) -
Carba‐Sugar Analogs of Glucosamine‐6‐Phosphate: New Activators for the glmS Riboswitch
por: Stängle, David, et al.
Publicado: (2022)